SCHEMBL5200736

SCHEMBL5200736

Cc1cccc(C)c1O.Cc1cccc(C)c1OC(=O)CCCNC(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
CA1 P00915 5/20 0.44
CA2 P00918 5/20 0.44
USP2 O75604 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CYP3A4 P08684 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GLA P06280 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1999900 0.95 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL3160634 0.80 CA1 (0.45) ALDH1A1MEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL29123845 0.77 TDP1 (0.50) ALDH1A1MEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL3959646 0.75 CA1 (0.58) ALDH1A1MEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL4597216 0.75 NQO2 (0.60) MEN1KMT2ACA1CA2TDP1
SCHEMBL21601421 0.74 L3MBTL1 (0.61) ALDH1A1SMN1; SMN2CYP2D6CYP2C19CA1
SCHEMBL27698153 0.74 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL27437838 0.73 TDP1 (0.62) MEN1KMT2ACA1CA2TDP1
SCHEMBL10792928 0.73 SMN1; SMN2 (0.59) ALDH1A1MEN1KMT2ASMN1; SMN2HSD17B10
SCHEMBL637737 0.73 GAA (0.52) ALDH1A1KMT2ACA1CA2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838687-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2007-10-03 EP disclosed
WO-2006073366-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2006-07-13 WO disclosed